ADAM ORTEGA: Open Payments
NPI 1114677739 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,307 in 140 payments from 26 companies in 2025. Trend: 2023 $2,852 · 2024 $2,284 · 2025 $2,307
Food & beverage: $2,307
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $420 |
| ABBVIE INC. | 30 | $414 |
| Amgen Inc. | 24 | $334 |
| Phathom Pharmaceuticals, Inc. | 5 | $165 |
| AstraZeneca Pharmaceuticals LP | 4 | $141 |
| Sumitomo Pharma America, Inc. | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| PFIZER INC. | 4 | $64 |
| Exact Sciences Corporation | 3 | $57 |
Products named: VOQUEZNA, Wegovy, VRAYLAR, OTEZLA, Ozempic, EVENITY, JARDIANCE, LINZESS.
Industry payments across TX — which companies pay providers there.
